Seizure-induced neuronal plasticity and metabolic effects
Metabolic Encephalopathy, Page: 113-135
2009
- 6Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures6
- Readers6
Book Chapter Description
Epilepsy, the most common acquired chronic neurological disease, occurs in 1% of the human population. Despite treatment with the newest antiepileptic medications, almost one-third of the individuals continue having seizures (Kwan and Brodie, 2000). Many of those with seizure persistence and even some with seizure-remittance suffer often from under-appreciated co-morbidities including cognitive deficits and psychopathology such as anxiety, depression, and poor attention. Our understanding of epileptogenesis and its concurrent effects is based mainly on animal models. Using humans with epilepsy to study effects of human epilepsy is fraught with multiple problems including ethics, medication effects, and reproducibility. More recently, however, human brain tissue from surgical-resections has been studied (this represents only a small subgroup of patients with epilepsy). Modern imaging techniques have also helped unveil widespread metabolic-abnormalities associated with epilepsy.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84919839069&origin=inward; http://dx.doi.org/10.1007/978-0-387-79112-8_7; http://link.springer.com/10.1007/978-0-387-79112-8_7; http://link.springer.com/content/pdf/10.1007/978-0-387-79112-8_7; https://dx.doi.org/10.1007/978-0-387-79112-8_7; https://link.springer.com/chapter/10.1007/978-0-387-79112-8_7
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know